Moderna
MRNA
726 hedge funds and large institutions have $15.6B invested in Moderna in 2026 Q1 according to their latest regulatory filings, with 148 funds opening new positions, 239 increasing their positions, 200 reducing their positions, and 85 closing their positions.
74% more first-time investments, than exits
New positions opened: 148 | Existing positions closed: 85
74% more capital invested
Capital invested by funds: $8.99B → $15.6B (+$6.64B)
20% more repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 200
8% more funds holding
Funds holding: 675 → 726 (+51)
0.15% more ownership
Funds ownership: 77.86% → 78.01% (+0.15%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
7% less call options, than puts
Call options by funds: $1.76B | Put options by funds: $1.89B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$822M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$274M |
| 3 |
Goldman Sachs
New York
|
+$124M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$106M |
| 5 |
Two Sigma Investments
New York
|
+$81.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$211M |
| 2 |
BlackRock
New York
|
-$134M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$105M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$70.2M |
MRNA Hedge Fund Activity: Q1 2026 in Review
726 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q1 2026, worth a combined $15.6B — up 74% from $8.99B a quarter earlier.
Buyers outnumbered sellers: 148 funds opened new MRNA positions and 85 closed out — a net gain of 63 holders — while 239 added to existing stakes and 200 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $822M. The largest seller was D.E. Shaw & Co, cutting an estimated $211M.
- 726 institutional investors held Moderna (MRNA) as of Q1 2026, up from 675 in Q4 2025.
- Funds reported $15.6B of Moderna stock for Q1 2026, up 74% quarter-over-quarter.
- 148 funds opened new Moderna positions in Q1 2026 and 85 closed out, a net change of +63 holders.
- The largest Moderna buyer in Q1 2026 was Fidelity Investments, an estimated $822M added.
- The largest Moderna seller in Q1 2026 was D.E. Shaw & Co, an estimated $211M sold.
Based on aggregated 13F filings for Q1 2026.